spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Alzheimer 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 9 Feb 2026
Lilly to Acquire Orna Therapeutics to Advance Cell Therapies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Dec 2025
Mercury Bio Announces Appointment of Casey Perkins as Vice President of Corporate Strategy & Business Development
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Dec 2025
SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Oct 2025
Brenig Therapeutics Names Megan McGill as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2025
Labcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
Diagnostics Neurology
 HSMN NewsFeed - 27 Aug 2025
Leal Therapeutics Announces $30 Million Series A to Progress First-In-Class Neuro-Metabolic Therapies for Neurodegenerative and Neuropsychiatric Disorders with High-Unmet Need
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 20 Aug 2025
Anne White to Retire as Executive Vice President and President, Lilly Neuroscience
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Aug 2025
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 28 Jul 2025
MapLight Therapeutics Announces $372.5 Million Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 14 Jul 2025
Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 10 Jul 2025
Klotho Neurosciences, Inc. Granted FDA Orphan Drug Designation for KLTO-202 for Treatment of Amyotrophic Lateral Sclerosis ("ALS" or "Lou Gehrig's Disease")
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 May 2025
Lilly Announces Transitions in Executive Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 7 Feb 2025
Most Patients on Lilly's Omvoh(R) (mirikizumab-mrkz) for Crohn's Disease Achieved Sustained Clinical Remission and Endoscopic Response at Two Years
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Oct 2024
Lilly's EBGLYSS(TM) (lebrikizumab-lbkz) Demonstrated Meaningful Improvement in Skin Clearance and Itch Relief in the Majority of Patients with Moderate-To-Severe Atopic Dermatitis Who Discontinued Dupilumab
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 16 Aug 2024
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 19 Jul 2024
Rona Therapeutics Raises $35 Million Series A+ Financing to Advance Innovative Metabolic siRNA Pipeline in Clinic and Next Generation RNA Platforms
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Devices Endocrinology Monitoring FDA
 HSMN NewsFeed - 5 Jun 2024
Lilly announces departure of Anat Ashkenazi, chief financial officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 8 Mar 2024
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 12 Jan 2024
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Diagnostics Neurology FDA
 HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 27 Dec 2023
Lilly Completes Acquisition of POINT Biopharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 4 Dec 2023
Sensorium Therapeutics Announces Appointment of Veteran Biotech Executive Alexandra Glucksmann, Ph.D., as CEO as the Company Progresses Toward the Clinic
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2023
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 29 Jun 2023
Lilly to Acquire Sigilon Therapeutics
Biopharmaceuticals Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 20 Jun 2023
Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Apr 2023
Lilly to Divest BAQSIMI to Amphastar
Biopharmaceuticals Endocrinology Mergers & Acquisitions
 HSMN NewsFeed - 14 Feb 2023
KeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jan 2023
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Nov 2022
Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure(R) Predict Prognostic Test for Alzheimer's Disease
Diagnostics Neurology Personnel
 HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 23 Sep 2022
iSyncWave EEG Scanner Receives FDA 510k Clearance
Devices Neurology FDA
 HSMN NewsFeed - 12 Aug 2022
Zeta Surgical Appoints Professor James Choi as Focused Ultrasound Lead in Push for Incision-less Brain Surgery
Devices Neurosurgery Personnel
 HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Jul 2022
DiamiR Biosciences Appoints Alidad Mireskandari, Ph.D., MBA, as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 7 Jun 2022
Eight out of Ten Patients Maintained Skin Clearance at One Year in Lilly's Lebrikizumab Atopic Dermatitis Monotherapy Trials
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 May 2022
Fifty Percent of Patients with Ulcerative Colitis Treated with Mirikizumab Achieved Clinical Remission at One Year in Lilly's Pivotal Phase 3 Study
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2022
Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Feb 2022
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Feb 2022
Biohaven and Pfizer Announce Positive Topline Results of Pivotal Trial of Rimegepant for the Acute Treatment of Migraine in China and South Korea
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 27 Jan 2022
SciSparc Presents New Leadership Lineup
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 6 Dec 2021
Biohaven Names CEO Vlad Coric, MD, Chairman Of The Board Of Directors And Matthew Buten, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Nov 2021
NURTEC(R) ODT Approved In Kuwait For Acute Treatment Of Migraine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2021
Jupiter Orphan Therapeutics, Inc. Announces New Corporate Name, Jupiter Neurosciences, Inc.
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Sep 2021
Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home
Devices Neurology Venture Capital
 HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 23 Aug 2021
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Aug 2021
Lilly Announces Leadership Changes and Formation of Neuroscience and Immunology Business Units
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2021
KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Jun 2021
Eisai Inc. Announces the Appointment of Dr. Andree Amelsberg as Vice President, U.S. Medical Affairs, Oncology Business Group
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 24 Jun 2021
Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Jun 2021
vasopharm GmbH Announces Results of the NOSTRA III Traumatic Brain Injury Phase III Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 May 2021
Stemedica Signs License Agreement with Pulthera, LLC for all Respiratory Indications including those related to COVID-19
Regenerative Medicine Licensing
 HSMN NewsFeed - 12 May 2021
ViewMind Inc Announces Appointment of Chief Executive Officer
Diagnostics Neurology Personnel
 HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology
 HSMN NewsFeed - 4 Jan 2021
Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team
Diagnostics Neurology Personnel
 HSMN NewsFeed - 4 Jan 2021
Biohaven Begins Pivotal Phase 3 Trial Of Troriluzole In Obsessive-Compulsive Disorder
Biopharmaceuticals
 HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2020
Neuroglee Therapeutics to Attack Alzheimer's Disease Through Personalized AI-Powered Digital Therapeutics
Devices Neurology Venture Capital
 HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 9 Nov 2020
DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer
Biopharmaceutical Drug Delivery Personnel
 HSMN NewsFeed - 19 Oct 2020
Diadem Names Clinical Diagnostics Industry Veteran Paul Kinnon as CEO
Diagnostics Neurology Personnel
 HSMN NewsFeed - 28 Sep 2020
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration for Elezanumab, an Investigational Monoclonal Antibody RGMa Inhibitor, for the Treatment of Spinal Cord Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 21 Jul 2020
Data from Lilly at Alzheimer's Association International Conference 2020(R) (AAIC 2020) to Showcase Clinical Advances in Alzheimer's Research
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 10 Jun 2020
Biohaven Appoints Bob Hugin to its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 13 May 2020
Optina Diagnostics receives 510(k) clearance from U.S. FDA for its MHRC-C1, permitting hyperspectral imaging of the retina
Devices Ophthalmology FDA
 HSMN NewsFeed - 30 Apr 2020
Alpha Cognition, Inc. Receives FDA/PMDA Regulatory Guidance for Alpha-1062 Alzheimer's Therapy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2020
Biohaven to Advance Vazegepant into Phase 3 for the Acute Treatment of Migraine Following Successful End of Phase 2 Meeting with FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Mar 2020
ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Feb 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2020
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Feb 2020
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2020
Martin Jönsson Appointed New CEO of AlzeCure Pharma
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Oct 2019
World Renowned Experts Appointed to Skyhawk Therapeutics Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2019
Axon Neuroscience Appoints Michal Fresser as Group CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 May 2019
True Diagnostics, Inc. Receives FDA 510(k) Clearance to Market VeriClear(TM) Digital Test Device for Early Result Pregnancy
Diagnostics FDA
 HSMN NewsFeed - 14 May 2019
Brain imaging AI leader icometrix raises $18 million in new funding
Devices Neurology Venture Capital
 HSMN NewsFeed - 1 May 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Apr 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 27 Mar 2019
Novartis receives FDA approval for Mayzent(R) (siponimod), the first oral drug to treat secondary progressive MS with active disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Mar 2019
Eisai and Imbrium Therapeutics Announce U.S. FDA Filing Acceptance of New Drug Application for Lemborexant for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Jan 2019
Functional Neuromodulation Announces CEO Leadership Transition
Devices Neurology Personnel
 HSMN NewsFeed - 17 Jan 2019
Asceneuron Appoints Peter Van Vlasselaer as Chairman
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jan 2019
Lisa Genova, Ph.D joins CereVasc Board of Directors
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 12 Dec 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 1 Nov 2018
Chris Cargill Appointed Executive Vice President and Chief Financial Officer of Sosei
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 13 Sep 2018
IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2018
Longeveron Appoints Arin Maercks Chief Commercial Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 23 Aug 2018
Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"
Devices Neurology FDA
 HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Jul 2018
Biohaven Receives FDA May Proceed Letter And Initiates Phase 2/3 Clinical Trial Of Trigriluzole (BHV-4157) In Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Jul 2018
Spruce Biosciences Appoints David Moriarty, Ph.D., as Vice President of Development Operations
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 9 Jul 2018
Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon(R) Patch
Biopharmaceuticals Neurology Generics Product Launch
 HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Jun 2018
Impel NeuroPharma Announces FDA Clearance of IND for Pivotal Phase 3 Study of INP104 for Acute Treatment of Migraine
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 12 Jun 2018
Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jun 2018
Partner Therapeutics (PTx) Announces US FDA Approval of Leukine(R) (sargramostim) for the Treatment of Acute Radiation Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Jun 2018
Sosei Announces Appointment of Chris Cargill as Interim CFO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 May 2018
Luye Pharma Acquires AstraZeneca's Signature Products Seroquel and Seroquel XR
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
Biopharmaceuticals Devices Drug Delivery FDA
 HSMN NewsFeed - 16 May 2018
EIP Pharma Secures $20.5 Million in Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 12 Apr 2018
FDA Permits Marketing of IDx-DR for Automated Detection of Diabetic Retinopathy in Primary Care
Devices Ophthalmology FDA Product Launch
 HSMN NewsFeed - 3 Apr 2018
Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Mar 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 9 Feb 2018
Boehringer Ingelheim refocuses PDE9 inhibition brain research on schizophrenia following results from Phase II Alzheimer's trials
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Jan 2018
INSIGHTEC Closes $150 Million Series E Financing
Devices Venture Capital
 HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 18 Dec 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Dec 2017
John Walsh, M.D. Joins EMD Serono as Vice President of Neurology & Immunology, US Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Nov 2017
Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board
Devices Personnel
 HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Sep 2017
Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier(R) as a Treatment for Life-Threatening Viruses
Devices FDA
 HSMN NewsFeed - 30 Aug 2017
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Aug 2017
Alkahest Appoints Helen Jenkins as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Aug 2017
Biohaven Appoints Julia P. Gregory to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital
 HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 23 Jun 2017
Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jun 2017
Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Diagnostics Oncology Personnel
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 May 2017
Merck Receives CHMP Positive Opinion Recommending Approval of ISENTRESS(R) (raltegravir) 600 mg in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 May 2017
Amgen Submits Biologics License Application To The FDA For Erenumab
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 May 2017
Accera Appoints Dr. Judith Walker as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 May 2017
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 10 Apr 2017
Non-Opioid Drug Development Firm, CerSci Therapeutics, Announces Appointment of Pharma Leaders Pat Confalone and Perry Molinoff to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2017
Axovant Sciences Announces Appointment of Dr. David Hung as Chief Executive Officer and Expansion of Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Mar 2017
FDA Approves Genentech’s OCREVUS(TM) (Ocrelizumab) for Relapsing and Primary Progressive Forms of Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Mar 2017
Reata Pharmaceuticals, Inc. Appoints David Chapman as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 23 Jan 2017
Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 22 Dec 2016
Positive Phase III Results of Genentech’s Investigational Medicine OCREVUS(TM) (Ocrelizumab) Published in New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Dec 2016
Biogen Names Michel Vounatsos Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Dec 2016
Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 9 Dec 2016
Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Nov 2016
Neurotrope Issues Statement On Eli Lilly's Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Nov 2016
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
Groundbreaking Team At Aquinnah Pharmaceuticals Adds Two New Members To Help Overcome The Challenge Of ALS And Alzheimer's Disease
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Nov 2016
FDA Grants Fast Track Designation for Development of E2609, Eisai's BACE Inhibitor for Early Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Nov 2016
Neurim Pharmaceuticals Announces Positive Top-Line Results from Pivotal Phase III Trial of Paediatric Prolonged-Release Melatonin (PedPRM) for Sleep Disturbances in Children with Autism Spectrum Disorders (ASD)
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2016
Alzheimer's Drug Development Company Cognition Therapeutics appoints Kenneth I. Moch President & CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Oct 2016
Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Sep 2016
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2016
Allergan and Adamas Announce Settlement with Amneal Related to NAMZARIC(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Aug 2016
Neurotrope Announces Changes to the Board of Directors and Management
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Aug 2016
Accera Appoints C. Evan Ballantyne as Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Jul 2016
John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2016
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jun 2016
OPKO Health to Acquire Transition Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Jun 2016
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 9 Jun 2016
NUEDEXTA(R) Effective for Pseudobulbar Affect (PBA) in Patients with Alzheimer's Disease and other Dementias, Stroke and Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 12 May 2016
Accera Completes Enrollment of Phase 3 NOURISH AD Study of AC-1204 for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Apr 2016
Pharnext Announces the Opening of the First U.S. Study Site for its PLEO-CMT International Pivotal Phase 3 Trial in Charcot-Marie-Tooth Disease Type 1A
Biopharmaceuticals
 HSMN NewsFeed - 11 Apr 2016
Beyhan Zaim appointed Vice President Commercial Development & Alzheimer's Disease Global Lead, Neurology Business Group at Eisai Inc.
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Apr 2016
Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Mar 2016
Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Mar 2016
Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 17 Feb 2016
FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine Ocrelizumab in Primary Progressive Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 3 Feb 2016
ProMIS Neurosciences announces identification of a second novel therapeutic target for Alzheimer's disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jan 2016
FDA Approves Eisai's Halaven(R) (eribulin mesylate) Injection for the Treatment of Patients with Advanced Liposarcoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jan 2016
Abide Therapeutics Appoints Richard N. Kender to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jan 2016
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 11 Jan 2016
ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 29 Dec 2015
Amarantus Requests Rare Pediatric Disease and Orphan Drug Designations from US FDA for Engineered Skin Substitute in the Treatment of Giant Congenital Melanocytic Nevi
Devices Regenerative Medicine Dermatology FDA
 HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Nov 2015
Calimmune Expands Board of Directors, Names R. Scott Greer as Chairman
Biopharmaceuticals HIV/AIDS Personnel
 HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology
 HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Oct 2015
Impel NeuroPharma Closes First Tranche of Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 Sep 2015
Marathon Pharmaceuticals Names Dr. Jordan Dubow Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2015
VBI Vaccines Promotes Dr. David E. Anderson to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2015
Intra-Cellular Therapies Expands Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jun 2015
Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif(R)) in Two Phase III Studies in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Jun 2015
vTv Therapeutics Appoints Rudy Howard as Chief Financial Officer
Biopharmaceuticals Neurology Endocrinology Personnel
 HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 14 May 2015
Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 8 Apr 2015
Alzheon Announces $10 Million Series A Financing
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Feb 2015
Topline Results of Phase 3 Trial Show Eribulin Mesylate Injection Meets Primary Endpoint of Overall Survival in Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Feb 2015
Pivotal Phase 3 Trial of Investigational Agent Lenvatinib in Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer Published in New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Jan 2015
NeuroPhage Expands Series D Financing To $27 Million
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Dec 2014
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 4 Nov 2014
NeuroPhage Appoints Industry Veteran Franz Hefti, PhD, President/COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2014
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Oct 2014
FDA Approves AKYNZEO(R) (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Sep 2014
Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Sep 2014
GE Healthcare Announces European Union Approval of VIZAMYL(TM) (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease
Biopharmaceuticals Devices Radiology Oncology Regulatory
 HSMN NewsFeed - 27 Aug 2014
Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta(R)/Revolade(TM) For Use in Patients with Severe Aplastic Anemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Jul 2014
ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jul 2014
Transition Therapeutics Appoints Carl Damiani as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jun 2014
CHMP Recommends EU Approval of VIZAMYL(TM) (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque
Biopharmaceuticals Radiology Neurology Regulatory
 HSMN NewsFeed - 23 Jun 2014
Barry Lederman Appointed Vice President and Chief Financial Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2014
Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2014
Nektar Appoints Ivan Gergel, M.D. as Senior Vice President, Drug Development & Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 May 2014
GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss
Devices Neurology Radiology Distribution
 HSMN NewsFeed - 8 May 2014
Anavex Appoints Senior Healthcare and Pharmaceutical Executives to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Apr 2014
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals Inc.
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 1 Apr 2014
Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer
Biopharmaceuticals Diagnostics Personnel
 HSMN NewsFeed - 31 Mar 2014
Eisai Assigns Its Worldwide Exclusive License for DACOGEN(R) to Otsuka
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Feb 2014
Actavis to Acquire Forest Laboratories, Inc. for ~$25 Billion in an Equity and Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2014
Zocere Appoints Zavitz as Chief Scientific Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 25 Jan 2014
Amorfix Announces Retirement of Walter von Wartburg
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2014
Neuralstem Appoints Catherine Angell Sohn To Board Of Directors
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2014
Cortice Biosciences Announces the Appointment of George Farmer, Ph.D. as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Jan 2014
Forma Therapeutics Appoints Christopher Dinsmore to Vice President, Medicinal and Computational Chemistry
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2014
Eisai Announces U.S. Availability of FYCOMPA(TM) (perampanel) CIII an Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy Age 12 and Older
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 16 Dec 2013
Neurotrope, Inc., Appoints James Gottlieb to the Company's Board of Directors
Biopharmaceuticals Diagnostics Neurology Personnel
 HSMN NewsFeed - 16 Dec 2013
Premier Biomedical Secures $5 Million Equity Funding From Kodiak Capital Group, LLC
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 2 Dec 2013
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Nov 2013
Guri Stark Joins CorTechs Labs as CEO
Devices Radiology Personnel
 HSMN NewsFeed - 21 Nov 2013
Otsuka and Lundbeck's Once-Monthly Abilify Maintena(R) (Aripiprazole) Now Approved in Europe for Maintenance Treatment of Schizophrenia in Adult Patients Stabilized with Oral Aripiprazole
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Nov 2013
Eisai Announces Availability of ACIPHEX(R) Sprinkle(TM) (Rabeprazole Sodium) for Treatment of GERD in Children Ages 1 to 11
Biopharmaceuticals Gastroenterology Product Launch
 HSMN NewsFeed - 7 Oct 2013
Neurotrope, Inc., Announces Hiring Robert Weinstein As Executive Vice President and Chief Financial Officer
Biopharmaceuticals Diagnostics Neurology Personnel
 HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Sep 2013
Neurotrack Raises $2 Million Series A Led by Founders Fund
Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 6 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Sep 2013
Neuralstem To Raise $4 Million In Registered Direct Offering
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2013
$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 26 Aug 2013
Sangamo BioSciences to Acquire Ceregene
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 14 Aug 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Aug 2013
FDA Grants Orphan Drug Status To Eisai's Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Aug 2013
Merz North America Announces the Appointment of John Donofrio as Chief Financial Officer and Head of North American Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2013
Perrigo Company to Acquire Elan Corporation, plc for US$8.6 Billion, Establishing Premier Global Healthcare Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jun 2013
Pluristem Enters Into Strategic Partnership and Licensing Agreement With Cha Bio&Diostech for the Development and Commercialization of PLX Cells for the Treatment of CLI and IC in South Korea
Regenerative Medicine Licensing
 HSMN NewsFeed - 7 Jun 2013
Eisai Announces Availability of BELVIQ(R) (lorcaserin HCl) CIV Tablets for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Devices
 HSMN NewsFeed - 20 May 2013
Elan Announces Transactions: Decisively Transforming the Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 May 2013
Third Rock Ventures Expands and Strengthens Team
Biopharmaceuticals Devices Venture Capital Personnel
 HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 May 2013
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2013
Adamas Pharmaceuticals Presents New Traumatic Brain Injury Data From Its Nurelin(TM) Program At American Academy Of Neurology Conference
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Mar 2013
Catalyst Pharmaceutical Partners Appoints Dr. Bernardino Mosquera as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2013
Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Jan 2013
AtheroNova Names New Clinical Affairs Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 26 Dec 2012
Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products
Biopharmaceuticals Diagnostics Neurology Acquisitions
 HSMN NewsFeed - 18 Dec 2012
AtheroNova Names New Chief Medical Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 17 Dec 2012
Naurex Completes $38 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 12 Dec 2012
Lilly Provides Update on Next Steps for Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Nov 2012
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Nov 2012
Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR(R) and Donepezil for Alzheimer’s Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 22 Oct 2012
Dr Roger M. Perlmutter Joins Heptares' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2012
BioAdvance Expands Team to Support Portfolio Companies and New Investments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Sep 2012
Merz, Inc. Announces Cynthia Schwalm as Vice President, Neurology
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Sep 2012
Higher dose of Novartis drug Exelon(R) Patch approved by FDA for patients with mild to moderate Alzheimer's disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Aug 2012
Eli Lilly and Company Announces Top-Line Results on Solanezumab Phase 3 Clinical Trials in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2012
Neuralstem Updates ALS Stem Cell Trial Progress; Emory University Institutional Review Board Approves Amendment
Biopharmaceuticals Regenerative Medicine Neurology
 HSMN NewsFeed - 1 Jun 2012
Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)
Biopharmaceuticals Radiology Neurology
 HSMN NewsFeed - 29 May 2012
Eisai Gains Positive CHMP Opinion for Fycompa(R) (perampanel) First in a New Class of Treatment for Partial Onset Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 22 May 2012
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 May 2012
Pfizer Inc. Issues Statement Regarding Pending Court Case
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Apr 2012
Oligomerix, Inc. Completes $2 Million Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 19 Apr 2012
EnVivo Pharmaceuticals Names Christopher L. Burnley Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2012
DA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Biopharmaceuticals Radiology Neurology FDA
 HSMN NewsFeed - 28 Mar 2012
Bristol-Myers Squibb and Meso Scale Discovery Enter Agreement to Develop Diagnostic Assays for Alzheimer’s Disease
Diagnostics Neurology
 HSMN NewsFeed - 20 Mar 2012
Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 19 Mar 2012
Merz Pharmaceuticals Introduces New Mederma(R) Advanced Scar Gel
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Mar 2012
The Merz Pharma Group Appoints William D. Humphries As New North American Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Feb 2012
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 16 Feb 2012
Mnemosyne Pharmaceuticals, Inc. Completes $5.4 Million Series A Round to Support Drug Discovery Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jan 2012
Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Dec 2011
Transition Therapeutics Announces the Departure of Its President and Chief Financial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 24 Oct 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Oct 2011
Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals
Biopharmaceuticals Devices Diagnostics
 HSMN NewsFeed - 12 Oct 2011
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Regenerative Medicine Neurology
 HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Sep 2011
Bristol-Myers Squibb and Saladax Biomedical Expand Collaboration for Diagnostic Assays for Alzheimer’s Disease
Diagnostics Neurology
 HSMN NewsFeed - 7 Sep 2011
iPierian Appoints Nancy Stagliano as CEO; Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2011
NeuroLogica Corporation Receives CE Mark for Its Portable, High-Resolution SPECT Camera, the inSPira HD(TM)
Devices Radiology Neurology Regulatory
 HSMN NewsFeed - 13 Jul 2011
Medivation Names Stewart Hallett Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Jun 2011
CerebralRx Enters Global Neuromodulation Market With the FitNeS(TM) System for Treating Epilepsy
Devices Neurology
 HSMN NewsFeed - 9 May 2011
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Apr 2011
FDA Issues Complete Response Letter for Aricept(R) Patch (donepezil transdermal system)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Apr 2011
Ligand Names Matthew W. Foehr Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2011
DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 11 Apr 2011
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Apr 2011
Pfizer and Medivation Announce Results From Phase 3 Horizon Trial of Dimebon in Huntington Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Mar 2011
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2011
Pico-Tesla Achieves Significant Regulatory Milestone
Devices Regulatory
 HSMN NewsFeed - 1 Mar 2011
NeuroPhage Pharmaceuticals Closes $12.4M Series B Round
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Feb 2011
ZELTIQ(TM) Starts 2011 by Strengthening Management Team
Devices Personnel
 HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Feb 2011
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Feb 2011
Neuralstem Updates ALS Clinical Trial Progress
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 Feb 2011
Neuralstem Receives FDA Orphan Designation for Spinal Cord Stem Cells for Treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Feb 2011
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
Devices Radiology Neurology
 HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Jan 2011
Ligand Acquires CyDex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jan 2011
James E. Shipley, M.D., Named Chief Medical Officer of Concert Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2011
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 10 Jan 2011
Neuroptix Closes C Round Financing
Devices Neurology Venture Capital
 HSMN NewsFeed - 15 Dec 2010
Pico-Tesla Starts Pilot Study of Magneceutical(R) Therapy For Fibromyalgia
Devices
 HSMN NewsFeed - 6 Dec 2010
Elan Names Robert A. Ingram Chairman-Designate
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Nov 2010
Lilly to Acquire Avid Radiopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2010
Ligand Announces Approval for Revolade(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Nov 2010
Spencer Pharmaceutical Partners With National Pharmaceutical in the Development of Central Nervous System Disease Treatments
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Oct 2010
AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Oct 2010
ACADIA Pharmaceuticals Enters Agreement with Biovail to Conclude Collaboration and Regain North American Rights to Pimavanserin
Biopharmaceuticals
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Oct 2010
Cortex Obtains Exclusive Worldwide Rights for the Combination of AMPAKINE(R) and mGluR5 Compounds for the Treatment of Fragile X
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 5 Oct 2010
Third Rock Ventures Appoints Steven Paul, M.D., as Venture Partner
Venture Capital Personnel
 HSMN NewsFeed - 16 Sep 2010
FluoroPharma Inc. Appoints Mr. Thijs Spoor as Chief Executive Officer and Director
Biopharmaceuticals Radiology Oncology Personnel
 HSMN NewsFeed - 8 Sep 2010
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Aug 2010
Neuralstem Files FDA Application for First Chronic Spinal Cord Injury Stem Cell Trial
Regenerative Medicine
 HSMN NewsFeed - 17 Aug 2010
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Aug 2010
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
U.S. District Court Rules Against Lilly Regarding Strattera Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Aug 2010
Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Aug 2010
Avid Radiopharmaceuticals Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
Biopharmaceuticals Radiology Neurology Personnel
 HSMN NewsFeed - 10 Aug 2010
DiaMedica Announces Dr. Michael Giuffre to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Aug 2010
David T. Howard Appointed Director of biOasis Technologies Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Aug 2010
FDA Approves Merz Pharmaceuticals' Xeomin(R) (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 24 Jul 2010
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Jul 2010
Integrated Diagnostics Secures $10 Million Second Tranche of Series A Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 14 Jul 2010
Vitae Pharmaceuticals Hires Christine Brennan, Ph.D. as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jul 2010
Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 22 Jun 2010
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM)
Devices Monitoring
 HSMN NewsFeed - 22 Jun 2010
Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer's Dementia
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2010
NormOxys Appoints Dr. John A. Hey Senior Vice President of Preclinical and Early Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jun 2010
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer's Disease Compounds
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 May 2010
Adeona Completes a $17.5 Million Corporate Partnership With Meda AB for the Development and Commercialization of Flupirtine for Fibromyalgia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 26 Apr 2010
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Apr 2010
Allon Therapeutics Announces Davunetide Receives FDA Fast Track Status for Treatment of Progressive Supranuclear Palsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Mar 2010
Eisai Submits Marketing Authorisation Application for Approval of Eribulin Mesylate in Europe, Based on Significant Overall Survival in Late Stage Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 30 Mar 2010
Medivation Announces Reduction in Workforce
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Mar 2010
Proteostasis Therapeutics Announces Additions of Key Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2010
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2010
Levia(R) Brings Personal Targeted Phototherapy Home as a Treatment Option for Millions of Psoriasis Patients
Devices Dermatology
 HSMN NewsFeed - 3 Mar 2010
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Feb 2010
FDA Approves Once-Daily MIRAPEX ER for the Treatment of Early Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2010
Merz to Complete Acquisition of BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Diagnostics Ophthalmology Licensing
 HSMN NewsFeed - 9 Feb 2010
Adeona Appoints James S. Kuo, M.D., M.B.A., as Chairman, CEO and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2010
KineMed Broadens Collaboration with Bristol-Myers Squibb
Biopharmaceuticals Personalized Medicine Neurology
 HSMN NewsFeed - 21 Jan 2010
Lupin Receives US FDA Tentative Approval for Memantine HCl Tablets
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 18 Jan 2010
HolGenTech to Demo Genome Based Prevention Model in Hand-Held Personal Genome Assistant at Personalized Medicine World Conference
Personalized Medicine
 HSMN NewsFeed - 13 Jan 2010
Population Diagnostics, Inc. Appoints Dr. Peggy Eis as Chief Technology Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2010
Merz to Acquire BioForm Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 22 Dec 2009
Applied NeuroSolutions Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and Company
Biopharmaceuticals Diagnostics Neurology
 HSMN NewsFeed - 17 Dec 2009
Medivation Announces Organizational Changes to Support Anticipated Growth and Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2009
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 10 Dec 2009
Lundbeck Names Sean Nolan as New CEO of its Lundbeck Inc. U.S. Subsidiary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2009
Applied NeuroSolutions Announces Renewal of Alzheimer's Disease Drug Discovery Collaboration with Eli Lilly and Company
Biopharmaceuticals Diagnostics Neurology
 HSMN NewsFeed - 4 Dec 2009
NormOxys Appoints Industry Veteran and Recognized Neuroscience Expert, Martin Tolar, MD, PhD, as Company's CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology
 HSMN NewsFeed - 13 Nov 2009
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2009
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Biopharmacetuicals Onocology
 HSMN NewsFeed - 12 Oct 2009
Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2009
Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Sep 2009
Elan Cures Breach of Tysabri(R) Collaboration Agreement and Amends Terms of Transaction with Johnson & Johnson
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Sep 2009
Schering-Plough Reports Data From SAPHRIS(R) (asenapine) Long-Term Schizophrenia Relapse Prevention Study
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2009
EnVivo Pharmaceuticals Names Stephen DiPalma Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2009
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Sep 2009
ACADIA Pharmaceuticals Announces Results from Phase III Trial of Pimavanserin in Parkinson's Disease Psychosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Aug 2009
VistaGen Appoints Industry Veteran Shawn Singh as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jul 2009
Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jul 2009
Stem Cell Therapeutics Corp. Receives Green Light to Begin Enrolling Patients in the India Phase IIb Acute Ischemic Stroke Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 1 Jul 2009
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Jun 2009
Eli Lilly and Company Announces New Drug Discovery Initiative
Biopharmaceuticals Oncology Endocrinology
 HSMN NewsFeed - 28 May 2009
Power3 Medical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer's
Diagnostics Neurology
 HSMN NewsFeed - 21 May 2009
Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing
Biopharmaceuticals Radiology Neurology Venture Capital
 HSMN NewsFeed - 18 May 2009
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
Diagnostics Neurology
 HSMN NewsFeed - 11 May 2009
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Diagnostics Neurology
 HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 May 2009
Biovail Enters into Collaboration and License Agreement with Acadia for Pimavanserin
Biopharmaceuticals Licensing Neurology
 HSMN NewsFeed - 21 Apr 2009
NeuroScience Pharmaceuticals Launches in Research Triangle Park
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2009
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2009
Pfizer Announces Operating Structure and Select Senior Leadership Posts to Be Effective Immediately Upon Close of Wyeth Acquisition
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 7 Apr 2009
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
Biopharmaceuticals Radiology Acquisitions
 HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2009
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
Diagnostics Neurology
 HSMN NewsFeed - 18 Mar 2009
Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2009
Revolutionary Genetic Test Now Available for Age-Related Macular Degeneration
Diagnostics Ophthalmology
 HSMN NewsFeed - 9 Mar 2009
Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil
Biopharmaceuticals Drug Delivery Neurology Licensing
 HSMN NewsFeed - 5 Mar 2009
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2009
Pfizer Discontinues Development of Two Phase 3 Compounds
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Feb 2009
Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 6 Feb 2009
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Jan 2009
Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jan 2009
A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2009
Howard Feldman Joins Bristol-Myers Squibb as Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 16 Dec 2008
Watson Pharmaceuticals Receives FDA Approval for Generic Razadyne(R) ER Capsules
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 25 Nov 2008
Roche signs definitive agreement to acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2008
Roche Signs Definitive Agreement to Acquire Memory Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Oct 2008
CoLucid Pharmaceuticals Names Linda Hogan VP of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
MDS Pharma Services Takes Novel Steps to Recruit Patients for Alzheimer’s Disease Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Oct 2008
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Carisbamate
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Oct 2008
EPIX Pharmaceuticals Announces Reduction in Force
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2008
Neuroptix Raises $18.5 Million in Successful B Round
Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Oct 2008
Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Sep 2008
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Sep 2008
Dr. Lars Ekman Joins Sofinnova Ventures
Venture Capital
 HSMN NewsFeed - 17 Sep 2008
Memory Pharmaceuticals Realigns Workforce to Support Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2008
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals
 HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Aug 2008
Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2008
New Data Highlight Positive Results of Namenda(R) (memantine HCl) Once-Daily Extended-Release Formulation
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jul 2008
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2008
FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 11 Jul 2008
Perrigo Company Announces Appointment of New Board Member
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2008
Neurobiological Technologies' CEO to Retire on December 31, 2008
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Jul 2008
Transition Therapeutics Announces Executive Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
Avid Appoints Richard A. Baron as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 Jun 2008
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Aspect Medical Systems Announces U.S. Sales Force Expansion Plan and Reaffirms Q2 Financial Guidance
Devices Monitoring
 HSMN NewsFeed - 22 May 2008
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
Return to NewsFeed  

 Additional items found! 500

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 500 additional stories matching:
Alzheimer
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.